Abstract
Mesangial proliferative nephritis (MesPGN) is a common kidney disease worldwide. The main feature of the disease is mesangial cell proliferation-induced injury to kidney function. In this study, we explored serum biomarkers for kidney function injury in anti-Thy1 nephritis. We found that mesangial proliferation were increased on days 5 and 7, and recovered by day 14 in anti-Thy1 nephritis. 24-h urine protein, the ratio of urine protein to urine creatine, serum creatine, and blood urea nitrogen, were increased at days 5 and 7 in the model. We found that TXN, BET1, PrRP, VGF, and NPS differed strongly from controls on days 5 and, associated with kidney injury when detected by SELDI-TOF MS. Moreover, we applied LC-MS to detect differential protein expression and found A2M, C3, ITIH4, ITIH3, VDBP, AFM, and SERPINF2 to be upregulated, and ES1, HPX, SERPINC1, SERPINA1F, SERPINA4, SERPINA3K, SPI, TF, VNN3, SERPINF1, and PON1 to be downregulated, on days 5 and 7, associated with kidney injury. The levels of VNN3 and VDBP were validated by Western blotting. Overall, this study explored a group of candidate biomarkers of mesangial proliferation inducing kidney injury, to provide the basis of an assessment model for MesPGN in the future.
References
Jun 20, 1998·The EMBO Journal·M SaitohH Ichijo
Apr 2, 2002·Biochemical and Biophysical Research Communications·Haleem J IssaqDonna Felschow
Oct 30, 2007·Proteomics·Sun-Hee HeoJe-Yoel Cho
Jul 4, 2008·Molecular & Cellular Proteomics : MCP·Danmei XuBenedikt M Kessler
Aug 12, 2009·Molecular & Cellular Proteomics : MCP·Zhuo ShenBai-Chen Wang
May 6, 2011·Kidney International·Tim FugmannChristoph Roesli
Sep 13, 2011·Toxicology·Keiko HosohataAkio Fujimura
Oct 1, 2011·The Journal of Steroid Biochemistry and Molecular Biology·Carolina R C DoorenbosMartin H de Borst
Dec 14, 2011·Molecular & Cellular Proteomics : MCP·Yang LuXiangmei Chen
Mar 28, 2012·Internal Medicine·Tsuyoshi NosakiHirohito Tsubouchi
Apr 28, 2012·The American Journal of Pathology·Claudia R C van RoeyenJürgen Floege
May 23, 2012·BMC Nephrology·Yanhong LiXing Feng
Jun 15, 2012·Clinical Rheumatology·Zhu ChenXiang-Pei Li
May 11, 2013·Journal of Nephrology·Xiao-Ling YinJian-Hua Zhou
Nov 13, 2013·Neuroimmunomodulation·Yuan YaoZhihai Lei
Dec 18, 2013·PloS One·Shiva KalantariRoman A Zubarev
Aug 12, 2014·Proteomics·Yang LuXiangmei Chen
Sep 24, 2014·Experimental Biology and Medicine·Pei WangZequan Ji
Dec 3, 2014·Neuroscience·W WangW Zhou
Jan 6, 2015·Journal of Dairy Science·Keelin O'DriscollBernadette Earley
Mar 10, 2015·Experimental and Molecular Pathology·Miloš ŠunderićOlgica Nedić
Apr 1, 2015·Proteomics. Clinical Applications·Dawn J CasterDavid W Powell
Jun 13, 2015·BioMed Research International·Marta KalousovaTomas Zima
Jul 6, 2015·Oncotarget·Stefan BusseMandy Busse
Aug 25, 2015·Clinical Laboratory·Jakob TriebelCarmen Clapp
Sep 12, 2015·Clinical and Experimental Nephrology·Yang LuXiangMei Chen
Citations
May 16, 2017·Clinica Chimica Acta; International Journal of Clinical Chemistry·Francesca ScebbaDebora Angeloni
Jun 15, 2018·Molecular Medicine Reports·Guoxing WanYonggang Zhang
Nov 12, 2019·Aging·Yan-Ru LiuHui-Yuan Zhu
May 14, 2021·Frontiers in Pharmacology·Yan-Ru LiuXin-Bo Shi